October 29, 2016

Inspirion Closes Deal with Japanese Giant

Inspirion Delivery Sciences LLC and Daiichi Sankyo, Inc. have entered into an agreement aimed at commercializing Inspirion’s new abuse-deterrent, pain management opioid, MorphaBond.  The agreement comes on the heels of FDA approval of the drug.  Daiichi is considered a leader in the U.S. pharmaceutical market. The company focuses on the […]